Subscribe

Hepatitis C Virus and HIV | Risk Factors for Hepatic Decompensation During Interferon-Ribavirin Therapy

Purpose:

To identify risk factors for hepatic decompensation in a patient coinfected with HIV and HCV who is being treated with interferon-ribavirin.

Specialty:

Infectious Diseases
Clinical Pharmacology & Toxicology
Gastroenterology

Objective:

risk factors, pharmacogenetics, adverse effects

ICD-10:

B17.1, B18.2

Description:

Bani-Sadr et al evaluated patients coinfected with HIV and hepatitis C virus (HCV) who had hepatic decompensation during interferon-ribavirin therapy. They identified risk factors which can help avoid this serious complication. The authors are from multiple hospitals in France.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone